Literature DB >> 36210429

Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer's Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation.

Saeid Bagheri-Mohammadi1, Sahar Askari1,2, Behrang Alani3, Maryam Moosavi4, Rasoul Ghasemi5.   

Abstract

Insulin signaling disruption and caspase-3 cleavage play a pathologic role in Alzheimer's disease (AD). Evidence suggested that cinnamaldehyde (Cin), the major component of cinnamon, has the ability to act as a neuroprotective agent. However, little evidence is available to demonstrate its effectiveness in regulating the insulin and caspase-3 signaling pathways and underlying molecular mechanisms. Therefore, the present study was conducted to correlate the molecular mechanisms of these signaling pathways and Cin treatment on animal behavioral performance in an intracerebroventricular (ICV)-streptozotocin (STZ, 3 mg/kg) model. The sporadic AD rat model was treated with Cin (10 and 100 mg/kg; intraperitoneal, i.p) daily for 2 weeks. Novel object recognition (NOR), Morris water maze (MWM), and elevated plus maze (EPM) tests were performed to assess recognition/spatial memory and anxiety-like behavior, respectively. Hippocampal Aβ aggregation was assessed using Congo red staining. The activity of hippocampal caspase-3 and IRS-1/Akt/GSK-3β signaling pathways were analyzed using the Western blot technique. The results revealed that Cin (100 mg/kg, effective dose) improved recognition/spatial memory deficits and anxiety-like behavior. In addition, Cin negated the effects of STZ on Aβ aggregation and caspase-3 cleavage in the hippocampus. Furthermore, the Western blot method showed that hippocampal IRS-1/AKT/GSK-3β phosphorylation was altered in ICV-STZ animal model, while Cin modulated this signaling pathway through decreasing Phospho.IRS-1Ser307/Total.IRS-1 ratio and also increasing Phospho.AktSer473/Total.Akt and Phospho.GSK-3βSer9/Total.GSK-3β ratios. These findings suggest that Cin is involved in the regulation of hippocampal IRS-1/AKT/GSK-3β and caspase-3 pathways in a sporadic AD model, and modulation of these signaling pathways also influences the animal behavioral performance.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Apoptosis; Cinnamaldehyde; Hippocampus; Insulin signaling pathway

Year:  2022        PMID: 36210429     DOI: 10.1007/s12031-022-02075-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  40 in total

1.  Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.

Authors:  Saeid Bagheri-Mohammadi; Behrang Alani; Mohammad Karimian; Rana Moradian-Tehrani; Mahdi Noureddini
Journal:  Mol Biol Rep       Date:  2019-05-23       Impact factor: 2.316

Review 2.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

Review 3.  Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation.

Authors:  Suzanne Craft
Journal:  Neurobiol Aging       Date:  2005-11-02       Impact factor: 4.673

4.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

5.  A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).

Authors:  Yanxing Chen; Zhihou Liang; Julie Blanchard; Chun-Ling Dai; Shenggang Sun; Moon H Lee; Inge Grundke-Iqbal; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Mol Neurobiol       Date:  2012-11-14       Impact factor: 5.590

6.  A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.

Authors:  Rahul Agrawal; Ethika Tyagi; Rakesh Shukla; Chandishwar Nath
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.250

7.  Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.

Authors:  Ansab Akhtar; Jatinder Dhaliwal; Priyanka Saroj; Ankit Uniyal; Mahendra Bishnoi; Sangeeta Pilkhwal Sah
Journal:  Inflammopharmacology       Date:  2020-01-03       Impact factor: 4.473

8.  Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.

Authors:  Ansab Akhtar; Mahendra Bishnoi; Sangeeta Pilkhwal Sah
Journal:  Brain Res Bull       Date:  2020-08-09       Impact factor: 4.077

Review 9.  Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Neurochem Res       Date:  2020-11-10       Impact factor: 3.996

10.  Trans-cinnamaldehyde protects C2C12 myoblasts from DNA damage, mitochondrial dysfunction and apoptosis caused by oxidative stress through inhibiting ROS production.

Authors:  Yung Hyun Choi
Journal:  Genes Genomics       Date:  2020-08-27       Impact factor: 1.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.